The type of treatment for Type 2 diabetes may determine how likely diabetic women, who are past their menopausal stage, would survive, according to a study by the Roswell Park Cancer Institute. The joint study by Roswell Park and the University of Buffalo researchers found that Metformin, an oral medicine, which controls type 2 diabetes, could play a role in reducing the risk of dying from cancer